Cargando…
Androgen receptor splice variants and prostate cancer: From bench to bedside
Therapeutic interventions for advanced prostate cancer (PCa) center on inhibiting androgen receptor (AR) and downstream signaling pathways. Resistance to androgen deprivation therapy and/or AR antagonists is inevitable and molecular mechanisms driving castration-resistant PCa (CR-PCa) primarily invo...
Autores principales: | Wadosky, Kristine M., Koochekpour, Shahriar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392349/ https://www.ncbi.nlm.nih.gov/pubmed/28077788 http://dx.doi.org/10.18632/oncotarget.14537 |
Ejemplares similares
-
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
por: Wadosky, Kristine M., et al.
Publicado: (2016) -
Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
por: Wadosky, Kristine M, et al.
Publicado: (2016) -
Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014) -
Androgen Receptor in Breast Cancer: From Bench to Bedside
por: Chen, Mengyao, et al.
Publicado: (2020) -
Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)